Armando RG - Search Results

1

Homology Model and Docking-Based Virtual Screening for Ligands of Human Dyskerin as New Inhibitors of Telomerase for Cancer Treatment.

Armando RG, Mengual Gómez DL, Juritz EI, Lorenzano Menna P, Gomez DE. Armando RG, et al. Int J Mol Sci. 2018 Oct 18;19(10):3216. doi: 10.3390/ijms19103216. Int J Mol Sci. 2018. PMID: 30340325 Free PMC article.

2

Telomere structure and telomerase in health and disease (review).

Gomez DE, Armando RG, Farina HG, Menna PL, Cerrudo CS, Ghiringhelli PD, Alonso DF. Gomez DE, et al. Among authors: armando rg. Int J Oncol. 2012 Nov;41(5):1561-9. doi: 10.3892/ijo.2012.1611. Epub 2012 Aug 29. Int J Oncol. 2012. PMID: 22941386 Free PMC article. Review.

3

AZT as a telomerase inhibitor.

Gomez DE, Armando RG, Alonso DF. Gomez DE, et al. Among authors: armando rg. Front Oncol. 2012 Sep 6;2:113. doi: 10.3389/fonc.2012.00113. eCollection 2012. Front Oncol. 2012. PMID: 22973556 Free PMC article.

4

[Telomerase and telomere: their structure and dynamics in health and disease].

Mengual Gómez DL, Armando RG, Farina HG, Gómez DE. Mengual Gómez DL, et al. Among authors: armando rg. Medicina (B Aires). 2014;74(1):69-76. Medicina (B Aires). 2014. PMID: 24561847 Free article. Review. Spanish.

5

Telomerase as a Cancer Target. Development of New Molecules.

Gomez DL, Armando RG, Cerrudo CS, Ghiringhelli PD, Gomez DE. Gomez DL, et al. Among authors: armando rg. Curr Top Med Chem. 2016;16(22):2432-40. doi: 10.2174/1568026616666160212122425. Curr Top Med Chem. 2016. PMID: 26873194 Free PMC article. Review.

6

AZT exerts its antitumoral effect by telomeric and non-telomeric effects in a mammary adenocarcinoma model.

Armando RG, Gomez DM, Gomez DE. Armando RG, et al. Oncol Rep. 2016 Nov;36(5):2731-2736. doi: 10.3892/or.2016.5094. Epub 2016 Sep 15. Oncol Rep. 2016. PMID: 27633795

7

Telomeropathies: Etiology, diagnosis, treatment and follow-up. Ethical and legal considerations.

Armando RG, Mengual Gomez DL, Maggio J, Sanmartin MC, Gomez DE. Armando RG, et al. Clin Genet. 2019 Jul;96(1):3-16. doi: 10.1111/cge.13526. Epub 2019 Mar 25. Clin Genet. 2019. PMID: 30820928 Review.

8

New drugs are not enough‑drug repositioning in oncology: An update.

Armando RG, Mengual Gómez DL, Gomez DE. Armando RG, et al. Int J Oncol. 2020 Mar;56(3):651-684. doi: 10.3892/ijo.2020.4966. Epub 2020 Jan 20. Int J Oncol. 2020. PMID: 32124955 Free PMC article. Review.

9

Rational design of PIN1 inhibitors for cancer treatment based on conformational diversity analysis and docking based virtual screening.

Maggio J, Cabrera M, Armando R, Chinestrad P, Pifano M, Menna PL, Gomez DE, Gómez DLM. Maggio J, et al. J Biomol Struct Dyn. 2022 Aug;40(13):5858-5867. doi: 10.1080/07391102.2021.1874531. Epub 2021 Jan 19. J Biomol Struct Dyn. 2022. PMID: 33463409

10

In vitro characterization and rational analog design of a novel inhibitor of telomerase assembly in MDA MB 231 breast cancer cell line.

Armando R, Cabrera M, Vilarullo R, Chinestrad P, Maggio J, Paderta C, Lorenzano Menna P, Gomez D, Mengual Gómez D. Armando R, et al. Oncol Rep. 2022 Nov;48(5):188. doi: 10.3892/or.2022.8403. Epub 2022 Sep 14. Oncol Rep. 2022. PMID: 36102322 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page